Current role
Julie Krop, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Julie Krop, M.D.
DiaMedica Therapeutics Inc. reported in an 8-K filed August 6, 2025 that Julie Krop, M.D. was appointed Chief Medical Officer, effective August 11, 2025.
“On July 31, 2025, the Company appointed Julie Krop, M.D., to serve as Chief Medical Officer of the Company, effective as of August 11, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-08-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DiaMedica Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Rick Pauls CEO, Board Member
- James Parsons Chairman
- Charles Semba Board Member
- Charles Semba, M.D. Board Member
- Daniel J. O'Connor Board Member
- Daniel O’Connor Board Member
- Michael Giuffre Board Member
- Michael Giuffre, M.D. Board Member
- Richard E. Kuntz, M.D., M.Sc. Board Member
- Richard Kuntz Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.